Hereditary Gynecologic Cancer: Risk, Prevention and Management fills the need that exists for a book addressing highly relevant clinical issues associated with the new field of hereditary gynecologic cancers. Written with the clinician in mind, the authors will cover a broad range of topics, beginning with an overview discussing clinical relevance of hereditary ovarian and hereditary endometrial cancers. Succeeding sections will provide in-depth analyses of Hereditary Breast Ovarian Cancer Syndrome, Lynch Syndrome, and other syndromes with gynecologic cancer components, and genetic risk assessment.
Hereditary Gynecologic Cancer: Risk, Prevention and Management:
- is the first clinically focused reference detailing gynecologic patient management issues of BRCA1 and BRCA2 mutation carriers
- includes a practical section on genetic risk assessment and genetic testing
- examines case studies to demonstrate management techniques and decision-making
- provides detailed discussion of ovarian cancer screening, prevention and risk reducing surgery
Clinical relevance of Hereditary Ovarian Cancer. Clinical relevance of Hereditary Endometrial Cancer. Molecular Genetics and Cancer Risks in BRCA1/2. Pathology of BRCA-associated ovarian cancers, including occult cancers. Ovarian cancer screening. Ovarian cancer prevention. Ovarian cancer risk reducing surgery. Breast Cancer Screening and Prevention. Management of mutation negative patients. Therapy and prognosis of BRCA associated ovarian cancer. Molecular Genetics and Cancer Risks in Lynch Syndrome. Pathology of Lynch-associated endometrial and ovarian cancers and use of molecular diagnostics. Endometrial and ovarian cancer screening and prevention. Colon Cancer and Other Lynch Cancers Screening and Prevention. Endometrial and ovarian cancer risk reducing surgery. Li-Fraumini Syndrome. Ovarian Cancer and BRCA1 and BRCA2. Endometrial Cancer and Lynch Syndrome. Genetic Discrimination. Psychologic impact of genetic testing.